Partner Courtenay Brinckerhoff is quoted in a Law360 article, “Fed. Circ. Clouds Landscape For Medical Treatment Patents,” about a recent appeals court decision invalidating claims of five Mallinckrodt patents on Inomax, a drug used to treat babies with breathing disorders.
Brinckerhoff said the ruling appears to foreclose patents on such methods of non-treatment, though it’s not clear what could make such claims patentable. “I think most of the Federal Circuit judges believe method-of-treatment claims where you’re actually treating someone are eligible,” she said. “My concern is the slippery slope of that line.”
People
Related News
29 November 2023
In the News
Daljit Doogal Discusses Foley’s Strategic Growth and Big Law Expansion Trends in Emerging Legal Markets
Foley & Lardner LLP Chairman and CEO Daljit Doogal is quoted in The American Lawyer article, “Big Fish, Small Ponds: How Big Law Is Slowly Infiltrating Emerging Markets,” offering insight on Foley’s continued national growth and Big Law expansion trends.
28 November 2023
In the News
Kyle Faget Discusses Coverage and Reimbursement for Telehealth Services
Foley & Lardner LLP partner Kyle Faget is interviewed by Healthcare IT Today in the article, “What’s a Problem, Technology, Opportunity, or Issue That Not Enough People are Talking About?”
22 November 2023
In the News
Naikang Tsao Assesses Copyright Act’s Fair Use Defense After Warhol Foundation v. Goldsmith
Foley & Lardner LLP partner Naikang Tsao authored the Westlaw Today article, “Still too subjective: the Copyright Act’s fair use defense after Andy Warhol Foundation v. Goldsmith.”